Spotlight: Somnus Gets OK for Anti-Snoring Device
- Share via
Sunnyvale-based Somnus Medical Technologies said it has received Food and Drug Administration approval for an anti-snoring device that shrinks tissues blocking the air passages of the sleep-deprived. The device aims to cure snoring and a more serious ailment, sleep apnea. About 40 million Americans suffer from habitual snoring, studies have found. The market for anti-snoring gadgets is about $275 million, according to privately held Somnus.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
